Skip to main content
. 2021 Jan 19;16(1):e0245678. doi: 10.1371/journal.pone.0245678

Table 1. Clinical characteristics of patients with obesity.

All Men Women P-value
n = 149 n = 46 n = 103
Age (years) 45.7±14.3 43.3±13.8 46.8±14.5 0.167
Height (cm) 161.7±8.5 171.3±5.0 157.5±5.9 < 0.001
Body weight (kg) 93.0 (80.0–108.9) 107.9 (96.9–134.1) 87.2 (77.8–97.9) < 0.001
BMI (kg/m2) 35.0 (31.7–40.9) 37.4 (32.5–46.9) 34.5 (31.4–40.2) 0.069
Subcutaneous fat area (cm2) 411.0 (318.4–530.3) 413.4 (271.8–597.8) 411.0 (325.5–514.9) 0.906
Visceral fat area (cm2) 190.3 (147.2–235.6) 230.9 (180.0–273.2) 178.1 (134.9–214.2) < 0.001
Fat mass (kg) 41.0 (33.9–49.5) 42.5 (34.0–60.2) 39.9 (33.8–49.0) 0.293
Fat mass/BW (%) 45.2 (40.6–50.2) 39.7 (34.7–47.2) 46.5 (43.5–50.6) < 0.001
Skeletal muscle mass (kg) 28.2 (24.2–32.9) 36.1 (32.5–40.0) 25.7 (23.1–28.5) < 0.001
Skeletal muscle mass/BW (%) 29.9 (27.1–32.8) 33.6 (29.3–36.9) 29.0 (26.7–31.1) < 0.001
Appendicular lean mass (kg) 20.1 (17.2–24.8) 26.5 (23.8–28.5) 18.5 (16.1–20.2) < 0.001
Appendicular lean mass/BW (%) 22.0 (19.6–24.5) 26.1 (21.8–28.1) 21.1 (19.3–23.1) < 0.001
SMI (kg/m2) 7.8 (7.0–8.9) 9.0 (8.4–9.7) 7.3 (6.8–8.2) < 0.001
Systolic blood pressure (mmHg) 138.0 (128.0–157.0) 136.0 (128.0–147.0) 138.0 (127.0–160.0) 0.638
Diastolic blood pressure (mmHg) 82.0 (75.0–92.0) 83.0 (77.0–88.5) 81.0 (73.0–93.0) 0.548
Triglycerides (mg/dL) 117.0 (84.5–158.5) 138.0 (76.8–190.0) 111.0 (85.0–154.0) 0.077
HDL-cholesterol (mg/dL) 43.0 (39.0–51.5) 40.0 (33.8–45.5) 45.0 (41.0–54.0) < 0.001
LDL-cholesterol (mg/dL) 116.3±28.3 110.1±28.3 119.1±27.9 0.072
Fasting glucose (mg/dL) 97.0 (90.0–107.0) 97.0 (90.0–111.5) 96.0 (90.0–106.0) 0.576
HbA1c (%) 5.8 (5.5–6.2) 5.8 (5.4–6.3) 5.8 (5.6–6.1) 0.939
IRI (μU/mL) 14.8 (9.6–21.6) 18.5 (14.1–23.6) 13.0 (8.8–19.7) 0.005
HOMA-IR 3.5 (2.3–5.2) 4.5 (3.0–6.1) 3.3 (2.0–4.8) 0.005
CRP (mg/dL) 0.19 (0.08–0.52) 0.15 (0.05–0.28) 0.23 (0.09–0.59) 0.029
Leptin (ng/mL) 25.6 (15.8–38.1) 16.0 (8.8–24.4) 29.7 (21.3–42.8) < 0.001
Irisin (ng/mL) 22.5 (19.2–27.0) 21.5 (18.3–27.2) 22.8 (19.6–27.0) 0.398
Physical function
AT (ml/kg/min) 11.3 (9.8–12.6) 11.3 (10.4–12.7) 11.3 (9.7–12.6) 0.697
Peak VO2 (ml/kg/min) 18.8 (15.3–21.0) 19.5 (15.9–23.2) 18.6 (15.2–20.7) 0.163
Peak HR (bpm) 147.0 (132.0–160.0) 143.5 (129.5–155.0) 149.0 (137.0–161.0) 0.155
Grip strength (kg) 26.2 (21.5–30.8) 35.6 (29.8–42.3) 23.3 (19.4–27.1) < 0.001
Gait speed (m/sec) 1.3 (1.2–1.4) 1.3 (1.1–1.3) 1.3 (1.2–1.4) 0.407
Leg strength (N-m) 137.1 (112.2–154.2) 163.7 (138.6–203.6) 128.3 (104.4–145.2) < 0.001
Leg strength/BW (N-m/kg) 1.5 (1.3–1.7) 1.6 (1.4–2.0) 1.4 (1.2–1.6) < 0.001
baPWV (cm/sec) 1335.8 (1204.9–1514.6) 1338.0 (1210.9–1460.1) 1333.5 (1197.5–1525.1) 0.818
RHI 1.82 (1.52–2.21) 1.99 (1.54–2.34) 1.77 (1.51–2.16) 0.136
Coronary risk factor
Hypertension, n (%) 62 (41.6) 25 (54.3) 37 (35.9) 0.035
Dyslipidemia, n (%) 39 (26.2) 18 (39.1) 21 (20.4) 0.016
Diabetes mellitus, n (%) 24 (16.1) 13 (28.3) 11 (10.7) 0.007
Postmenopausal, n (%) - - 39 (37.9) -
Alcoholic drinks, n (%) 66 (44.3) 20 (43.5) 46 (44.7) 0.893
Current smoker, n (%) 16 (10.7) 6 (13.0) 10 (9.7) 0.544
Exercise habits, n (%) 37 (24.8) 15 (32.6) 22 (21.4) 0.142

Data are expressed as mean ± standard or median (interquartile range).

BMI, body mass index; BW, body weight; SMI, skeletal muscle index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; IRI, immunoreactive insulin; HOMA-IR, homeostasis model assessment of insulin resistance; CRP, C-reactive protein; AT, anaerobic threshold; VO2, oxygen consumption; HR, heart rate; baPWV, brachial-ankle pulse wave velocity; RHI, reactive hyperemia index.